Hospital Sector Stocks: Right Time to Invest for 5 Years? Apollo, KIMS, Rainbow Analysis

Is It the Right Time to Invest in the Hospital Sector?

The hospital sector stocks and whether it is the right time to invest; let me suggest a few good hospital stocks. Many people have been looking at this sector. Personally, I believe there is significant money to be made here.

We often discuss how hospitals are good businesses and how, as shareholders, we can generate wealth in the long run. Setting that aside, I clearly see a specific opportunity in the hospital sector right now. However, I will also explain how to capitalize on this opportunity.

This is because there are many people with a specific mindset—when a sudden event occurs, they often don’t know how to handle it; they panic and sell off their holdings. If we know how to play the situation correctly during times like that, we can turn it into an opportunity.

The Recent Correction in hospital sector stocks

For instance, if you look at the last month, shares of excellent hospital chains have fallen significantly.

In fact, most hospital stocks have undergone a correction of 10% to 20%.

Why Did This Correction Happen?

The reason for this correction is a recent statement from the Supreme Court regarding oncology drugs—specifically noting that their MRPs were abnormally high. This has caused concern among many that price caps might be imposed on hospital billing, which would impact profitability.

We recently saw the impact on insurance stocks when the IRDAI imposed a cap; those stocks underwent a massive correction. Many fear a similar scenario could play out for hospitals.

Why Hospitals Are Different From Insurance

However, one must remember that hospitals offer services, not just a single product. If a price cap is introduced—say, for a specific procedure—hospitals are smart enough to add another service to recover the costs.

Imposing price caps on certain treatments is nothing new; what we are seeing in the news now isn’t unprecedented. Price caps were imposed as recently as 2017 for knee replacement procedures.

Regarding knee replacement, has the overall cost gone up or down? Many people in your family have likely undergone knee replacement surgery, right? Ask those who have had it done—compare the price from five years ago to the current price. The costs have certainly increased, haven’t they?

So, what happens then? For instance, if price caps are imposed on specific hospital treatments or services, hospitals might cleverly try to inflate the bill by adding various other services under different names.

Structural Shortage Supports Pricing Power

Furthermore, we are already facing a significant shortage of hospitals relative to our population. In such a context, I believe imposing price caps is not straightforward.

Insurance is different—it involves a single product—whereas hospitals [hospital sector stocks] offer a wide range of services; even if a cap is placed on a specific service or product, they will find other ways to collect the money.

While this isn’t ideal for patients, if you ask me how to capitalize on this opportunity from an investor’s perspective—that’s a different conversation.

My Investment Strategy

Suppose I intended to allocate ₹100—I would immediately allocate ₹30. Since most hospital sector stocks have undergone a significant correction, I plan to invest the remaining funds in tranches. If there is any regulatory announcement, I will turn aggressive in my buying.

The reason for this aggressive stance is that, practically speaking, imposing price caps is not feasible; there is a shortage of hospitals, and hospital care involves a “bouquet” of services. Even if price caps are imposed on specific services, they will find ways to recover the costs elsewhere—meaning bills will likely rise rather than fall.

Beyond Standard Metrics: What I Look For

While everyone looks at standard metrics like beta, multiples, and other financials when investing in hospital sector stocks—and I do too—there are a few specific factors I consider beyond just those.

For instance, whether a company is listed on the Main Board or the SME exchange doesn’t really matter to me. When investing in hospital stocks—even if it is a small hospital—the key factor to consider is the reputation and drive of the promoter running it; specifically, do they have the hunger to grow the business?

We have witnessed this firsthand with institutions like KIMS, Yashoda, or the Asian Institute of Gastroenterology. If you compare the situation now to fifteen years ago, the growth has been massive across these hospital chains run by reputed doctors.

Where doctors themselves are at the helm, the growth has occurred on a massive scale. This is because a strong reputation automatically attracts patients, leading to business growth.

Consequently, even smaller hospitals—including those recently emerging in the SME space—are worth considering. If a hospital has a good reputation and is run by a very good doctor—someone who previously worked at a reputable organization before starting and successfully managing this one—and if they show a drive for growth, then such hospitals are certainly worth considering.

So, you don’t necessarily have to stick only to the main board; you can choose other hospitals too, but there is clearly an opportunity here.

Final Thoughts

I can sense an opportunity here, and we can definitely make a lot of money. I say this from a practical standpoint: don’t panic; instead, view it as an opportunity.

I know that if such regulations are introduced, there might be panic selling for a few days or a week; try to capitalize on that panic selling as much as possible. You will make a lot of money—that is exactly what I would do.